Sign in

CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824151574
Phone
(877) 742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
  1. 4 Open-market sale Chief Operating Officer sold 1,118 shares at $8.00 ($8,944)
  2. 4 Open-market sale CFO and CBO sold 1,291 shares at $8.00 ($10,328)
  3. 4 Open-market buy Director bought 12,500 shares at $7.93 ($99,084)
  4. 4 Open-market buy Director bought 10,000 shares at $8.12 ($81,248)
  5. 4 Open-market sale Chief Operating Officer sold 10,901 shares at $11.72 ($127,760)
  6. 4 Open-market sale CFO and CBO sold 4,325 shares at $11.72 ($50,689)
  7. 4 Open-market sale President and Chief Executive sold 33,848 shares at $11.72 ($396,699)
  8. 4 Grant or award CFO and CBO acquired 7,500 shares (grant or award)
  9. 4 Grant or award Chief Operating Officer acquired 7,500 shares (grant or award)
  10. 4 Grant or award Director acquired 25,000 shares (grant or award)
  11. 4 Grant or award Director acquired 10,500 shares (grant or award)
  12. 4 Grant or award Director acquired 10,500 shares (grant or award)
  13. 4 Grant or award Director acquired 10,500 shares (grant or award)
  14. 4 Grant or award Director acquired 10,500 shares (grant or award)
  15. 4 Grant or award Director acquired 10,500 shares (grant or award)
  16. 4 Grant or award Director acquired 10,500 shares (grant or award)
  17. 4 Grant or award Director acquired 10,500 shares (grant or award)
  18. 4 Open-market sale CFO and CBO sold 3,435 shares at $11.10 ($38,129)
  19. 4 Open-market sale President and Chief Executive sold 16,851 shares at $9.11 ($153,513)
  20. 3 Insider Initial Statement of Ownership

Page 4 of 12 · 224 filings